-
The Mental Health Burden of Rare Diseases Based on Insights From Patients and Caregivers Through Rarepulse® Social Listening
Sep 9, 2025, 16:22 PM -
The Impact of Burosumab on the Clinical and Economic Burden of X-Linked Hypophosphatemia in Adult Patients in France
Sep 9, 2025, 16:22 PM -
Social Determinants of Health Affecting Response to Opioid Addiction Treatment
Sep 9, 2025, 16:22 PM -
Navigating Implementation of the EU HTA Regulation for Medical Devices: Insights From National HTA Bodies Across Europe
Sep 9, 2025, 16:22 PM -
Evaluating the Impact of Implementing AI-Assisted Contouring on Radiotherapy Staff and Workflows
Sep 9, 2025, 16:22 PM -
Therapeutic Drug Monitoring and Selective Use of Glucarpidase in High-Dose Methotrexate Therapy: A Cost Analysis From the Algerian Payer Perspective
Sep 9, 2025, 16:22 PM -
COVID-19's Effects on Mental Health Services: The Effectiveness of Telepsychiatry and Challenges in Substance Use Disorders in the United States
Sep 9, 2025, 16:22 PM -
Socioeconomic Burden Among Children and Adults With Achondroplasia in Europe and Latin America
Sep 9, 2025, 16:22 PM -
Advanced Therapies and the Unmet Need in Systemic Lupus Erythematosus Patients: Results From a Real-World Study in the United States and Germany
Sep 9, 2025, 16:22 PM -
Modeling the Future Clinical and Environmental Burden of Chronic Kidney Disease in Ghana and Uganda Between 2025 and 2030
Sep 9, 2025, 16:22 PM -
Spinal Muscular Atrophy Treatments in France: What Are the Organizational Economic and Environmental Impacts of Oral and Intrathecal Administrations
Sep 9, 2025, 16:22 PM -
The Economic Burden of Inflammatory Arthritis: A Systematic Review
Sep 9, 2025, 16:22 PM -
Improving Time to Patient: Insights From the Canadian Cancer Treatment Hackathons
Sep 9, 2025, 16:22 PM -
Potential Impacts of Improvement in Turnaround Time
Sep 9, 2025, 16:22 PM -
Advancing a Greener Ecosystem in Health Technology Assessment: A Review of Environmental Integration as an Additional Value Driver
Sep 9, 2025, 16:22 PM -
What About a Latent Cure Model? Assessing Cure Models’ Performance in Pediatric Acute Lymphoblastic Leukemia Treated With Tisagenlecleucel
Sep 9, 2025, 16:22 PM -
An AI-Enhanced Targeted Literature Review Workflow to Support Inclusive Research Practices and Population Science Research: A Human-in-the-Loop Approach
Sep 9, 2025, 16:22 PM -
A Matching-Adjusted Indirect Comparison (MAIC) of Rucaparib vs. Niraparib in the Maintenance Treatment of Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer (aOC) After Response to First-Line Platinum-Based Chemotherapy
Sep 9, 2025, 16:22 PM -
Adoption and Evidence Generation in NICE Early Value Assessments (EVA) for Medtech: Trends Across 2023-2025
Sep 9, 2025, 16:22 PM -
Is Less More? Aggregating Health States in State Transition Models
Sep 9, 2025, 16:22 PM
